cPRC1 members have been shown to be upregulated in breast cancer cells regulating the expression of oncogenic active enhancers such as oestrogen receptor alpha (ERα) and BRD4-containing enhancers in triple-negative breast cancer (TNBC) (23). The gene discussed is ESR1; the disease is triple-negative breast carcinoma.